[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- [More, More, More - Nuclear Energy, That Is...]( [See How Investors Could Benefit From the Nuclear "Renaissance"]( --------------------------------------------------------------- December 13, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [Military Defense Impacted by Domestic Uranium Shortage?]( people know that the U.S. military's nuclear fleet is the largest uranium fuel consumer in the world. About 160 U.S. ships are powered by over 200 small nuclear reactors. While most are submarines, some icebreakers and aircraft carriers are also nuclear-powered. Unfortunately, current U.S. reliance on Russian state-owned sources for our uranium supply leaves our entire nuclear energy sector - including defense - vulnerable to geopolitical conflict such as Russia's war against Ukraine. [See the Factors Creating New Uranium Investment Opportunities]( --------------------------------------------------------------- [Arcellx Inc, ACLX]( Recent Analyst Action: Jason Gerberry, analyst at Bank of America Securities, reiterates coverage on [Arcellx Inc (ACLX)](in the Healthcare sector with a Buy rating and a price target of $37.00 (10 hours ago). - Recent Price: $30.09 - Average Analyst Price Target: $36.50 (21.30%) - Market Cap: $1.25B [TipRanks.com]( also reports that [Arcellx Inc](currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $36.50. The target pricing ranges from a high forecast of $39.00 down to a low forecast of $34.00. [Arcellx Inc (ACLX)](’s last closing price was $30.09 which would put the average price target at $36.50. Here are 3rd party ratings for [ACLX](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 22% (56 out of 249) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]( [Click here]( for the name of the one ticker you need to protect yourself. --------------------------------------------------------------- [Fluence Energy, FLNC]( Recent Analyst Action: Julien Dumoulin, analyst at Bank of America Securities, reiterates coverage on [Fluence Energy (FLNC)](in the Industrial Goods sector with a Sell rating and a price target of $13.00 (2 weeks ago). - Recent Price: $22.295 - Average Analyst Price Target: $18.67 (-16.26%) - Market Cap: $2.97B [TipRanks.com]( also reports that [Fluence Energy](currently has 3 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $18.67. The target pricing ranges from a high forecast of $25.00 down to a low forecast of $13.00. [Fluence Energy (FLNC)](’s last closing price was $22.295 which would put the average price target at $18.67. Here are 3rd party ratings for [FLNC](: - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Bottom 34% (163 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [DocuSign, DOCU]( Recent Analyst Action: Tyler Radke, analyst at Citigroup, reiterates coverage on [DocuSign (DOCU)](in the Technology sector with a Buy rating and a price target of $72.00 (1 day ago). - Recent Price: $57.99 - Average Analyst Price Target: $56.20 (-3.09%) - Market Cap: $10.87B [TipRanks.com]( also reports that [DocuSign](currently has 18 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $56.20. The target pricing ranges from a high forecast of $84.00 down to a low forecast of $38.00. [DocuSign (DOCU)](’s last closing price was $57.99 which would put the average price target at $56.20. Here are 3rd party ratings for [DOCU](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: sell - Zacks.com: Buy, Bottom 44% (138 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [The Best Deal In the History of Investing Research]( Street insiders, billionaires, and CEOs have paid us $103 MILLION to access our investing expertise... [but you can get access today for $1!]( --------------------------------------------------------------- [Replimune Group, REPL]( Recent Analyst Action: Evan Seigerman, analyst at BMO Capital, reiterates coverage on [Replimune Group (REPL)](in the Healthcare sector with a Buy rating and a price target of $70.00 (1 day ago). - Recent Price: $26.55 - Average Analyst Price Target: $47.00 (77.02%) - Market Cap: $1.30B [TipRanks.com]( also reports that [Replimune Group](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $47.00. The target pricing ranges from a high forecast of $70.00 down to a low forecast of $34.00. [Replimune Group (REPL)](’s last closing price was $26.55 which would put the average price target at $47.00. Here are 3rd party ratings for [REPL](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 24% (59 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [Phreesia, PHR]( Recent Analyst Action: John Ransom, analyst at Raymond James, reiterates coverage on [Phreesia (PHR)](in the Technology sector with a Buy rating and a price target of $40.00 (1 day ago). - Recent Price: $35.07 - Average Analyst Price Target: $34.09 (0.31%) - Market Cap: $1.70B [TipRanks.com]( also reports that [Phreesia](currently has 11 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $34.09. The target pricing ranges from a high forecast of $40.00 down to a low forecast of $26.00. [Phreesia (PHR)](’s last closing price was $35.07 which would put the average price target at $35.18. Here are 3rd party ratings for [PHR](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 48% (128 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [The Lithium "Lie"]( you know each electric car battery requires 220 pounds of graphite - more than lithium, copper, or aluminum? China controls more than 90% of this vital ingredient. But the U.S. just classified graphite as "essential for America's National Defense"... and one little-known company is looking to win big in the energy war with China. [Find Out How Investors Can Benefit From the Energy War with China]( --------------------------------------------------------------- [HashiCorp, HCP]( Recent Analyst Action: Alex Henderson, analyst at Needham, reiterates coverage on [HashiCorp (HCP)](in the Technology sector with a Hold rating (5 days ago). - Recent Price: $32.83 - Average Analyst Price Target: $39.14 (19.22%) - Market Cap: $6.05B [TipRanks.com]( also reports that [HashiCorp](currently has 8 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $39.14. The target pricing ranges from a high forecast of $42.00 down to a low forecast of $34.00. [HashiCorp (HCP)](’s last closing price was $32.83 which would put the average price target at $39.14. Here are 3rd party ratings for [HCP](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Buy, Top 22% (55 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [Accolade, ACCD]( Recent Analyst Action: Dev Weerasuriya, analyst at Berenberg Bank, reiterates coverage on [Accolade (ACCD)](in the Technology sector with a Buy rating and a price target of $13.00 (3 weeks ago). - Recent Price: $9.74 - Average Analyst Price Target: $13.20 (35.52%) - Market Cap: $647.45M [TipRanks.com]( also reports that [Accolade](currently has 11 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $13.20. The target pricing ranges from a high forecast of $16.00 down to a low forecast of $10.00. [Accolade (ACCD)](’s last closing price was $9.74 which would put the average price target at $13.20. Here are 3rd party ratings for [ACCD](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 44% (138 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Elon Musk and Bill Gates Agree On Nuclear Energy?]( Elon Musk to Bill Gates to politicians on both sides of the aisle, powerful people are now backing the expanded use of nuclear energy. They believe that safe, advanced nuclear technologies will play a vital role in our clean energy transition. Unfortunately, we're far too dependent on Russia for our uranium supply. That's why we desperately need more DOMESTIC sources of the yellow metal that fuels nuclear reactors. [See Why Uranium Should Now Be On Every Investor's Radar]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software